Peak6 Investments LLC Intercept Pharmaceuticals, Inc. Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $44,428 - $93,460	-4,845 Reduced 57.07%	3,644 $40,000
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $106,367 - $184,296	8,489 New	8,489 $114,000
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $25,896 - $34,031	-282 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $4,203 - $6,196	49 Added 21.03%	282 $28,000
Q3 2018 Nov 13, 2018	BUY	$88.49 - $127.55 $20,618 - $29,719	233 New	233 $29,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.